Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-FR Version v5-EN
Language French English
Date Updated 2018-08-29 2018-08-14
Drug Identification Number 00035017 00035017
Brand name ISOPTO ATROPINE ISOPTO ATROPINE
Common or Proper name ISOPTO ATROPINE 1% SOLUTION 5ML ISOPTO ATROPINE 1% SOLUTION 5ML
Company Name ALCON CANADA INC ALCON CANADA INC
Ingredients ATROPINE SULFATE ATROPINE SULFATE
Strength(s) 1% 1%
Dosage form(s) SOLUTION SOLUTION
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 5ML 5ML
ATC code S01FA S01FA
ATC description MYDRIATICSAND CYCLOPLEGICS MYDRIATICSAND CYCLOPLEGICS
Reason for discontinuation Other (Please describe in comments) Other (Please describe in comments)
Anticipated discontinuation date
Actual discontinuation date 2018-03-13 2018-08-15
Remaining supply date 2018-12-31 2018-08-14
Discontinuation status Reversed Reversed
Discontinuation decision reversal yes yes
Tier 3 Status No No
Information on remaining supply
Company comments WILL NOT BE DISCONTINUED. Product is now available. Novartis Pharmaceuticals has moved to a tight and timely management of inventory for continuity of supply of Isopto Atropine throughout Canada Will not be discontinued. Product expected to be available within the next weeks. Novartis Pharmaceuticals will move to a tight and timely management of inventory for continuity of supply of Isopto Atropine throughout Canada
Health Canada comments